黄小银, 王靖华. NK/T细胞淋巴瘤发病机制研究进展[J]. 中国肿瘤临床, 2013, 40(6): 367-370. DOI: 10.3969/j.issn.1000-8179.2013.06.016
引用本文: 黄小银, 王靖华. NK/T细胞淋巴瘤发病机制研究进展[J]. 中国肿瘤临床, 2013, 40(6): 367-370. DOI: 10.3969/j.issn.1000-8179.2013.06.016
Xiao-yin HUANG, Jing-hua WANG. Research progress in the pathogenesis of NK/T-cell lymphoma[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2013, 40(6): 367-370. DOI: 10.3969/j.issn.1000-8179.2013.06.016
Citation: Xiao-yin HUANG, Jing-hua WANG. Research progress in the pathogenesis of NK/T-cell lymphoma[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2013, 40(6): 367-370. DOI: 10.3969/j.issn.1000-8179.2013.06.016

NK/T细胞淋巴瘤发病机制研究进展

Research progress in the pathogenesis of NK/T-cell lymphoma

  • 摘要: NK/T细胞淋巴瘤(NK/T cell lymphoma, NKTCL)属高度侵袭性肿瘤, 预后差, 目前尚无明确有效的治疗方案。除了组织形态改变及EBV相关, 该病也存在染色体异常、基因突变、信号通路及蛋白表达的异常。国内外学者由此出发, 对其发病机制进行了持续的深入研究。本文就NKTCL发病机制的研究进展作一综述。

     

    Abstract: NK/T-cell lymphoma has a poor prognosis because of the invasiveness of this disease.No effective treatments exist for this condition.Aside from causing histologic and EBV-related changes, the disease also causes chromosome abnormality, gene mutation, and abnormality in the signal pathway and protein expression.Thus, many domestic and international scholars have conducted sustainable in-depth studies on the pathogenesis of the tumor.This paper summarizes the research progress on the pathogenesis of NK/T-cell lymphoma.

     

/

返回文章
返回